featured
2016 Top Stories in Eye Care: The Medical Treatment Guidelines for Diabetic Macular Edema
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Wells JA, Glassman AR, Ayala AR, et al. Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. Ophthalmology. 2016;123(6):1351-1359.
- The Diabetic Retinopathy Clinical Research Network. Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema. N Engl J Med. 2015;372(13):1193-1203.
- Bressler SB, Glassman AR, Almukhtar T, et al. Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema. Am J Ophthalmol. 2016;164:57-68.
- Calvo P, Abadia B, Ferreras A, et al. Diabetic macular edema options for adjunct therapy. Drugs. 2015;75(13):1461-1469.